Secondary transactions in funds legal nuances for the seller of an interest

Content

Since 2016 I have been leading COREDO and each quarter I personally oversee secondary fund transactions: from LP-led assignments to complex GP-led processes. During this time the COREDO team has implemented dozens of structures in the EU, the UK, Singapore, Cyprus, Estonia, the Czech Republic, Slovakia and Dubai. I see how entrepreneurs and CFOs want transparency and speed, yet face LPA restrictions, ROFR/ROFO procedures, AML checks and tax uncertainty when selling an LP interest cross-border. In this article I have compiled practical steps, legal nuances and pricing strategies to answer the central question: how to sell a stake in a private fund safely, at a fair price and without wasting time.

COREDO’s practice confirms: a well-prepared seller of a fund interest obtains a more predictable result, reduces the discount to NAV and shortens the closing timeline. I will lay out all the key stages, reveal the legal requirements for the transfer of fund units and show exactly where a deal usually “gets stuck” and how to avoid it.

What are secondary deals in funds?

Illustration for the section «What are secondary deals in funds» in the article «Secondary deals in funds - legal nuances for the seller of a stake»

Secondary deals in funds are transactions for the sale of already existing investor interests in private equity or other closed‑end funds. At the core is the transfer of an LP interest in a limited partnership or units in another legal form of the fund with replacement of the investor and transfer of all rights and obligations. For the seller it is a route to liquidity before the fund’s life ends; for the buyer — an opportunity to enter the portfolio at a later stage at a discount to NAV and with an accelerated time-to-liquidity.

I distinguish two basic formats: GP-led vs LP-led secondary deals. LP-led, the classic sale of an LP interest initiated by the investor; GP-led: the manager’s (GP’s) initiative for a restructuring: continuation vehicle, strip‑sale, tender offer for existing LPs and new buyers. Each format carries different negotiation dynamics, conflicts of interest for the GP when selling, and choices of pricing mechanics.

Market liquidity of fund interests remains lower than that of public instruments, so price is sensitive to time-to-liquidity, the quality of portfolio companies, and fee structure. ROI assessment is built through IRR and MOIC taking into account the remaining term and potential exit events. Our experience at COREDO has shown that proper packaging of information and early work with the GP reduce the discount and speed up approvals.

How to sell a stake in a private fund

Illustration for the section «How to sell a stake in a private fund» in the article «Secondary deals in funds — legal nuances for the seller of a stake»

To sell a stake in a private fund through a clear and controlled scheme, you need a precise step‑by‑step process that starts with legal and commercial diagnostics. First of all, the LPA, side letters and existing restrictions are checked to identify risks and determine the optimal transaction strategy.

LPA and side letters assessment

The first thing I do with the seller is conduct a review of the Limited Partnership Agreement (LPA) and side letters. Transfer restrictions in the LPA determine whether a sale is permissible, whether GP consent is required for the sale of the stake and whether a right of first refusal (ROFR) or ROFO/Pre‑emption rights apply. I also analyze drag‑along and tag‑along provisions on the sale of the stake, as well as the impact of side letters on the ability to sell the stake and on disclosure to the buyer.

We discuss with the GP in advance the mechanics and forms of GP consent, as well as the LPAC approval process and the role of investor committees. Communication rules with investors and transaction confidentiality are critical: I recommend signing an NDA and establishing consistent messaging to avoid leaks and breaches of the fund’s public statement provisions.

Stake valuation by NAV and discount to NAV

Valuation of a stake in secondaries traditionally relies on NAV‑based pricing. The price is formed as the NAV at the reference date minus the discount to NAV, which reflects time‑to‑liquidity, portfolio quality, marketability discount and minority discount. Discount to NAV vs negotiated price is always a matter of negotiation, where fee leakage on transfer, retention of GP fees and possible future capital calls are taken into account.

To strengthen the seller’s position, the COREDO team organizes a valuation opinion and an independent valuation of the stake using multiple methods: analysis of NAV dynamics, comparable secondary transactions, portfolio stress tests, exit scenarios, sensitivity of IRR and MOIC to timing, as well as the impact of post‑closing obligations, including clawback.

Data room and checklist for Due Diligence

How to prepare for the due diligence process? I always start with the data room: the LPA and all amendments, side letters, the latest capital account statements, GP reports, notices of capital calls and distributions, communications on ROFR/ROFO, confirmations of tax residency, KYC files, statements confirming the absence of sanctions, copies of certificates of interest registration, any emails with the GP regarding the transfer of the stake. The COREDO team prepares a due diligence checklist for the seller and the buyer in advance and synchronizes it with the requirements of the GP and the buyer.

In parallel we prepare a legal opinion sample on capacity and authority to close issues of the seller’s legal capacity and the signatories’ authority in advance. Notarisation and apostille (notarisation and apostille of the deal documents) are built into the timeline taking jurisdictional deadlines into account.

Auction, tender offer and sales channels

The secondary auction process and tender offer mechanics allow widening the buyer funnel and achieving a better price. In LP‑led processes we often launch a limited auction via confidential invitations, and in GP‑led transactions we support a tender offer with a clear timeline and package approvals.

To access demand I use different channels: market platforms for secondary transactions, the role of placement agents and brokers in secondaries, as well as direct syndications among familiar institutional investors. The solution developed at COREDO is a hybrid approach: a short teaser on the platform, selection of anchor buyers and parallel negotiations through a broker for price testing.

GP consent, LPAC and co-investors’ rights

The approval process with LPAC and investors begins after finalizing commercial terms. We test the right of first refusal (ROFR), comply with ROFO/Pre‑emption rights, notify the GP and obtain GP consent. In GP‑led structures I additionally focus on conflicts of interest at the GP during the sale and ensure transparency of the procedure for the LPAC, including an independent fairness opinion where appropriate.

I pay attention to transfer restrictions in the corporate documents of portfolio companies. If an LP interest carries indirect rights to SPV shares or side pockets, approvals may be required at the level of the underlying entities. I separately analyze voting rights and governance post‑sale so the buyer understands the scope of influence in advance.

Contractual architecture: PSA and escrow

The legal linkage usually includes a purchase and sale agreement for the fund stake (PSA) and an assignment and assumption agreement. In the PSA we set out the price and its calculation mechanism, escrow and holding of funds in escrow for secondaries, the practice and rationale for escrow holdback percentages, escrow release triggers and dispute escalation procedures, as well as post‑closing price adjustment mechanisms.

Seller representations and warranties in secondary transactions are focused: ownership of the interest, absence of encumbrances, authority, tax status, absence of sanctions. To cover the risk of rep & warranty claims I use W&I insurance for secondaries where economically justified, and negotiate an indemnity cap and holdbacks to cover liabilities. How to ensure enforcement of indemnities after closing? We set survival periods, offset mechanisms, escrow and arbitration triggers.

A separate block covers governing law and dispute jurisdiction (arbitration seat). In cross‑border deals I prefer English law with arbitration at LCIA or ICC; I discuss arbitration vs court litigation taking enforceability and speed into account.

Obligations and waterfall at closing

At closing we deliver documents to the GP, register the transfer in the fund register and carry out settlements via escrow. Transferee liability for capital call obligations after transfer is an important point: the buyer assumes future capital calls, but the parties agree on the allocation of pre‑closing obligations. Clawback exposure and how to mitigate it are addressed through caps, promissory notes and clarification of the waterfall.

I closely monitor the impact on the fund waterfall and the allocation of carried interest so that no party is surprised. The COREDO team carefully documents all agreed deviations, maintains document retention and subsequent compliance after closing to address regulatory and reporting matters.

Legal nuances of selling a stake in a fund

Illustration for the section «Legal nuances of selling a stake in a fund» in the article «Secondary deals in funds- legal nuances for the seller of a stake»

Legal nuances when selling a stake in a fund determine the range of possible risks and affect how to minimize them. Particular attention should be paid to LPA restrictions, the procedure for obtaining necessary consents and compliance with confidentiality requirements, since these factors most often become the source of disputes and obstacles to the transaction.

Consents and LPA confidentiality

LPA provisions on transfers of interests often require multi-step notifications and adherence to deadlines. The GP consent mechanics and consent forms vary from a simple letter to a complex consent agreement, sometimes with conditions regarding the absence of adverse tax impact. The LPAC approval process and the role of investor committees become key in GP-led restructurings, where I always insist on a clear protocol and disclosure of benefits to LPs.

I mitigate side letter disclosure risks for the seller by limited disclosure via a data room, where information is available only to vetted participants. Failure to follow investor communication rules and confidentiality of the transaction leads to loss of GP trust and delays in approval.

AML/KYC and sanctions checks

Anti-money laundering requirements (AML) in the sale of a stake cannot be underestimated. KYC and Enhanced Due Diligence for sellers of fund interests include identification, sources of funds, PEP screening and enhanced due diligence indicators, as well as sanctions screening. Checking the buyer’s reliability and sanctions screening are part of my personal responsibility, since this is where stop-factors most often emerge.

AML/CFT programs and FATF requirements for the transaction set the standards, and KYC providers and automated screening speed up the process. We additionally consider FATCA/CRS reporting consequences for the seller, requirements for disclosure of the beneficial owner when selling a stake and disclosure to beneficial ownership registers (EU BO registers).

Requirements and regulatory notifications

Jurisdictional registration specifics of a transfer of a stake in the EU and Asia determine where a notary is required, where an apostille is needed, and where only corporate resolutions suffice. We prepare the regulatory notifications and filings checklist at the outset to avoid the legal consequences of transferring a stake without notifying the regulator: from fines to the recognition of the transfer as invalid for local accounting purposes.

In cross-border cases I reserve time for notarial procedures and check whether a local agent for notification services or registration of a PSA in the registers is required. This reduces the risk of challenge and speeds up the release of escrow.

Structuring SPV, nominee and taxes

Structuring a deal through a nominee or trustee is not always suitable, but is useful where the buyer needs anonymity in public registers while undergoing full KYC within a closed circle. I compare offshore SPV structures versus onshore structures through the lens of economic substance and substance requirements for SPVs, as well as anti-avoidance rules and substance testing in the EU/Asia.

The tax block covers tax residency (tax residency assessment), withholding tax regimes in popular European jurisdictions, transfer taxes and registration fees on transfer of a stake, the application of double tax treaty relief to secondaries, as well as tax gross-up clauses and their use to neutralize unexpected withholdings. BEPS and substance requirements cannot be ignored, and we model the potential impact of BEPS Pillar II on the payment structure in advance.

The economic logic of pricing

Illustration for the section «Economic logic of pricing» in the article «Secondary deals in funds - legal nuances for the seller of a stake»

The pricing approach should rely on a transparent economic logic that allows one to relate market value and expected return. In the following subsections we will examine the role of NAV, methods of applying discounts and the importance of an independent valuation to justify the final price.

Independent valuation of NAV and discounts

NAV-based pricing methodologies for valuing secondaries may seem simple, but the devil is in the details. Discount to NAV is determined by a combination of factors: duration‑risk, portfolio quality, marketability discount and minority discount methodology, as well as market liquidity at the time of the transaction. We go through Discount to NAV vs negotiated price criteria with the seller, demonstrating to the buyer a well‑reasoned cash‑flow model.

Valuation opinion and an independent valuation of the stake increase confidence, especially in GP-led scenarios. During negotiations I fix a clear reference date, a true‑up mechanism for the closing date and carve-outs from the price for fee leakage.

ROI and negotiation strategy

IRR and MOIC as ROI metrics in secondaries form the basis of argumentation for both buyer and seller. I demonstrate the influence of time‑to‑liquidity on the deal price through exit scenarios and stress tests for delayed distributions. Pricing strategies when selling a minority stake include step‑pricing thresholds, alternative payout structures and the option of deferred payment upon reaching triggers.

Price negotiation tactics for the seller of a stake rely on a competitive process, clear deadlines and control of disclosure. Once we fix the main parameters, we shift the emphasis in the PSA to protection against «creeping» adjustments.

Settlement terms and protection of the parties

Escrow arrangements and holding funds in escrow in a secondary reduce the risk of post‑closing disputes. I structure escrow holdback percentage practice and rationale based on the risk profile of reps, taxes and possible delays in GP consent. W&I insurance coverage for reps and warranties is appropriate when the deal size justifies the premium and is needed to de‑risk the parties.

I address the risk of Rep & warranty claims and limitation of liability through indemnity cap, de minimis and basket. Escrow release triggers and dispute escalation I formalize in advance, including mediation and arbitration with a clearly defined seat.

Taxes on the Sale of an LP Interest in the EU and Asia

Illustration for the section «Taxes on the Sale of an LP Interest in the EU and Asia» in the article «Secondary deals in funds — legal nuances for the seller of an interest»

Taxes on the sale of an LP interest vary significantly between the EU and Asia: rules for determining the tax base, withholding rates and the availability of relief depend on the jurisdiction. First, let’s look at the European specifics: withholdings, reliefs and ancillary fees that affect the final deal amount.

Withholdings, Reliefs and Fees in the EU

Taxation of the sale of a fund interest in the EU differs by country: in some places capital gains tax applies, in others an exemption applies if the holding period and substance are met. Withholding tax on cross‑border secondaries is rarely applied to the sale of the interest, but arises in relation to related payments. I confirm the application of double tax treaty relief to secondaries with certificates of residence and formal notifications.

Transfer taxes and registration fees on the transfer of an interest arise in certain jurisdictions and are important to include in the pricing model. In the EU I also take into account beneficial ownership registers (EU BO registers) and potential disclosures to balance confidentiality and compliance.

Asia’s Anti‑avoidance Rules

Tax consequences for the seller of an interest in Asia depend on the fund’s status, place of management and local anti‑avoidance rules. In Singapore and Hong Kong we analyze in detail the source‑based approach and substance requirements to confirm the absence of PE risks. Withholding tax and transfer taxes vary, and access to DTT requires precise structuring.

Beneficial owner disclosure risks and data leakage in Asia are lower than in the EU, but requests from regulators and banks have increased. I will pre‑agree with the escrow bank the format of KYC/CRS and FATCA/CRS reporting consequences for the seller, so as not to delay the timeline.

Optimizing Transaction Costs

Strategies to minimize tax burden by lawful means include using appropriate DTT jurisdictions, sufficient substance, treaty clearance and tax rulings where available. Transaction costs — the calculation of legal and tax expenses — become part of negotiations, and sometimes it is beneficial to include a tax gross‑up for unforeseen withholdings.

The COREDO team prepares tax memoranda with assumptions and scenarios so that the seller understands the range of the after‑tax price even before the auction starts. This increases confidence and speeds up decision‑making.

Project management and timeline

A clearly defined timeline helps meet deadlines, and thoughtful project management reduces risks and speeds up decision-making. Below we’ll review a typical work schedule and approval process to understand responsibility for each milestone and the key control points.

Typical approval schedule

Closing timelines for a secondary deal and a typical timeline look like this: 1–2 weeks for preparing the data room and teaser; 3–4 weeks for marketing and negotiations; 2–3 weeks for GP/LPAC approvals; 1–2 weeks for documentation and closing. The timing of consent solicitations / typical timeline depends on committee schedules and the GP’s internal procedures.

Secondary auction process and tender offer require a clear schedule and disciplined communications. I build in a buffer for notarisation and apostille, as well as for banks’ KYC procedures for escrow accounts.

Communication channels

Confidentiality agreements and public statements govern what exactly and to whom may be disclosed at each stage. Data room contents: financial, legal documents, correspondence with the GP, tax certificates and AML packages. I set Q&A rules and limit direct contacts with the GP until the moment of an official request for consent.

Market platforms for secondary transactions provide access to a wide pool of investors, and the role of placement agents and brokers in the secondary market increases competition and supports the process. The result: higher-quality offers and transparent feedback.

Cost control and legal clarity

Transaction costs: the calculation of legal and tax expenses is transparent: legal fees, valuation, W&I insurance, banking fees and notary payments. Legal opinion on capacity and authority, regulatory notifications and filings checklist, and document retention create the legal soundness of the transaction and reduce the risk of post-closing disputes.

The COREDO team coordinates KYC providers, escrow banks, notaries and translators so the seller does not lose time on operational routine. This frees up focus for negotiations on price and terms.

COREDO Case Studies: Europe and Asia

Recently the COREDO team executed an LP-led deal to sell an LP interest in a Luxembourg buyout fund. The LPA contained a strict ROFR, and side letters limited disclosure. We conducted a secondary auction process among five buyers, obtained a valuation opinion, and recorded a discount to NAV of 7% with a time-to-liquidity of less than two years. GP consent took 12 business days, LPAC approved the deal on the condition of an escrow of 5% for 12 months. The PSA included an indemnity cap of 10% of the price and LCIA arbitration. Result: closing in 9 weeks, with no post-closing claims.

In Asia I personally led a GP-led continuation vehicle for late-stage assets in Singapore (VCC). We addressed the GP’s conflict of interest in the sale with an independent fairness opinion and a transparent tender offer for existing LPs. Buyers entered via onshore SPVs with sufficient substance, and sellers avoided unnecessary withholdings thanks to double tax treaty relief. An 8% escrow covered reps and tax covenants, and escrow release triggers were tied to the completion of regulatory notifications. These examples of previous precedent transactions in Europe and Asia show how preparation and discipline reduce the discount and accelerate the process.

Seller’s checklist for a fund interest

To minimize the legal risks of the seller, I use the following documentary checklist for a seller of a fund interest:

  • LPA, amendments, side letters and register of transfer restrictions.
  • Latest capital account statements, GP reports, notices regarding capital calls and distributions.
  • Tax residence certificates, DTT analysis and assessment of withholding tax.
  • KYC/AML package, PEP/sanctions screening, confirmation of sources of funds.
  • Data room contents: agreements, correspondence with GP, draft consent, LPAC materials, valuation opinion.
  • Purchase and sale agreement for the fund interest and a sample assignment and assumption agreement.
  • W&I term sheet, escrow agreement with holdback and release triggers.
  • Legal opinion on capacity and authority, notarial and apostille forms.
  • Regulatory notifications and filings checklist for all involved jurisdictions.
  • Post-closing plan: capital call obligations, clawback, waterfall, document retention and compliance.

Additionally I prepare a tactical negotiation plan: target discount-to-NAV range, counter-offer tactics, terms of price adjustment mechanisms post-closing and a strategy for disclosing side letters without breaching confidentiality. This speeds up the deal and keeps the price within the model boundaries.

Partner for complex secondaries

Secondary transactions in private equity funds require legal precision, tax architecture, AML discipline and careful coordination with GPs and the LPAC. I acknowledge that there is no ‘magic button’ here: limitations in the LPA, ROFR, sanctions checks, substance and BEPS are a reality that must be respected. That is why I structure the process so that each step has a clear deadline, a responsible executor and a clear outcome.

COREDO’s experience in the EU, the UK, Singapore, Cyprus, Estonia, the Czech Republic, Slovakia and Dubai helps reduce the discount to NAV, compress timelines and lower legal and tax risks. The COREDO team operates as a single point of contact: from LPA analysis and agreeing GP consent to preparing the PSA, escrow and closing, including AML/KYC and regulatory notifications. If you are considering selling a fund stake – whether selling an LP interest in a limited partnership or a complex GP-led restructuring,, I will propose a clear plan, a realistic timeline and solutions proven in practice.

As a result you will obtain liquidity without unnecessary losses, preserve the reputation of a reliable counterparty and lay the foundation for subsequent transactions on better terms. That is the goal of COREDO’s work: to be your long-term partner where law, finance and strategy intersect.

COREDO – EU Legal & Compliance Services Expert legal consulting, financial licensing (EMI, PSP, CASP under MiCA), and AML/CFT compliance across the European Union. Headquartered in Prague, we provide seamless regulatory solutions in Germany, Poland, Lithuania, and all 27 EU member states.

LEAVE AN APPLICATION AND GET
A CONSULTATION

    By contacting us you agree to your details being used for the purposes of processing your application in accordance with our Privacy policy.